Gene · 1445
Papers4,278
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 4,278
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Nod-like receptors in inflammatory arthritis. | Biomed J | 2024 | 37598797 | PubTator, text mining | PubMed |
| Molecular modelling, docking and network analysis of phytochemicals from Haritaki churna: role of protein cross-talks for their action. | J Biomol Struct Dyn | 2024 | 37288779 | PubTator, text mining | PubMed |
| Between Meanings and Senses-Making Spaces: Agency and Ownership Emergence Formalization from Cultural-Historical Activity Theory Position, for an AI-Friendly Model. | Integr Psychol Behav Sci | 2024 | 37193931 | PubTator, text mining | PubMed |
| Explanatory review on pyrimidine/fused pyrimidine derivatives as anticancer agents targeting Src kinase. | J Biomol Struct Dyn | 2024 | 37144746 | PubTator, text mining | PubMed |
| Integration of fingerprint-based similarity searching and kernel-based partial least squares analysis to predict inhibitory activity against CSK, HER2, JAK1, JAK2, and JAK3. | Mol Divers | 2024 | 36648693 | PubTator, text mining | PubMed |
| Recent advances of small-molecule c-Src inhibitors for potential therapeutic utilities. | Bioorg Chem | 2023 | 39492169 | PubTator, text mining | PubMed |
| Elucidating the susceptibility to breast cancer: an in-depth proteomic and transcriptomic investigation into novel potential plasma protein biomarkers. | Front Mol Biosci | 2023 | 38304232 | PubTator, text mining | PubMed |
| Identifying actionable druggable targets for breast cancer: Mendelian randomization and population-based analyses. | EBioMedicine | 2023 | 38251461 | PubTator, text mining | PubMed |
| LIMS-Kinase provides sensitive and generalizable label-free in vitro measurement of kinase activity using mass spectrometry. | Cell Rep Phys Sci | 2023 | 38213501 | PubTator, text mining | PubMed |
| The Regulation of Exosome Generation and Function in Physiological and Pathological Processes. | Int J Mol Sci | 2023 | 38203424 | PubTator, text mining | PubMed |
| Role of c-Src in Carcinogenesis and Drug Resistance. | Cancers (Basel) | 2023 | 38201459 | PubTator, text mining | PubMed |
| Signaling network analysis reveals fostamatinib as a potential drug to control platelet hyperactivation during SARS-CoV-2 infection. | Front Immunol | 2023 | 38187394 | PubTator, text mining | PubMed |
| Therapeutic targeting of p90 ribosomal S6 kinase. | Front Cell Dev Biol | 2023 | 38169775 | PubTator, text mining | PubMed |
| Oncoviruses: Induction of cancer development and metastasis by increasing anoikis resistance. | Heliyon | 2023 | 38144298 | PubTator, text mining | PubMed |
| Ca2+ Signaling and Src Functions in Tumor Cells. | Biomolecules | 2023 | 38136610 | PubTator, text mining | PubMed |
| Bruton's tyrosine kinase-bearing B cells and microglia in neuromyelitis optica spectrum disorder. | J Neuroinflammation | 2023 | 38129902 | PubTator, text mining | PubMed |
| Pyroptosis-related gene signature: A predictor for overall survival, immunotherapy response, and chemosensitivity in patients with pancreatic adenocarcinoma. | Heliyon | 2023 | 38125471 | PubTator, text mining | PubMed |
| Combined Immunodeficiency Caused by a Novel Nonsense Mutation in LCK. | J Clin Immunol | 2023 | 38112969 | PubTator, text mining | PubMed |
| NOS3 and CTH gene mutations as new molecular markers for detection of lung adenocarcinoma. | PeerJ | 2023 | 38107574 | PubTator, text mining | PubMed |
| A Novel Biallelic LCK Variant Resulting in Profound T-Cell Immune Deficiency and Review of the Literature. | J Clin Immunol | 2023 | 38100037 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1445/papers?page=7